AnBogen Therapeutics
Anbogen Therapeutics is a precision oncology company committed to bring innovative treatments to cancer patients.
Taiwan
18 employees
Series A
Total: $19.80M
Biotechnology
General Information
Taiwan
BounceWatch is an independent company data service, not affiliated with AnBogen Therapeutics. To contact AnBogen Therapeutics, visit anbogen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does AnBogen Therapeutics compare?
A PDF of AnBogen Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting AnBogen Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is AnBogen Therapeutics on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Taiwan Market
Biotechnology
About AnBogen Therapeutics
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | $7.30M | 1 |
|
01 Jul 2024 |
| Series A | $12.50M | 4 |
-logo.jpg){kind=logo}
|
31 Jan 2024 |
AnBogen Therapeutics Alternatives & Competitors
View All Alternatives
Avistone is an Innovative Global Oncology Company Focused on Targeted Therapeutics for Lung Cancer
Precision Oncology, Redefined.
Developing novel treatments at the forefront of oncology
FAQ About AnBogen Therapeutics
Source: BounceWatch company record for AnBogen Therapeutics, https://bouncewatch.com/company/anbogen-therapeutics, updated 30 December 2024. When citing, please name BounceWatch and link this page.
